comparemela.com

Latest Breaking News On - Global rare - Page 5 : comparemela.com

XNK Therapeutics appoints Dr Anna-Karin Maltais as CSO

XNK Therapeutics appoints Dr Anna-Karin Maltais as CSO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Karolinska institutetJohan liwingChiesi farmaceuticiAnna karin maltaisProduct developmentBiotech researchChief scientific officerKarin maltaisGlobal rare

FDA to Review Velmanase Alfa for Alpha-Mannosidosi

The FDA has accepted for Priority Review the Biologics License Application (BLA) for velmanase alfa for the treatment of alpha-mannosidosis.

Giacomo chiesiDrug administrationPriority reviewBiologics license applicationInborn errorsAnnual symposiumChiesi global rarePrescription drug user fee actGlobal rare diseasesGlobal rareAccessed september

Chiesi Global Rare Diseases Announces Presentations on Lysosomal Storage Diseases at the Society for the Study of Inborn Errors of Metabolism Annual Symposium

Results from the clinical development programme developed with Protalix BioTherapeutics evaluating pegunigalsidase alfa (PRX-102) an investigational enzyme.

United statesUnited kingdomFriuli venezia giuliaAlpha mannosidosisEtoile alphaUma ramaswamiChiesi farmaceuticiNathalie guffonGiacomo chiesiMaurizio scarpaB corpGroup chiesiLisbon north hospital center portugalProtalix ltdBerry company public relationsProtalix biotherapeutics

Chiesi Global Rare Diseases Announces Support for Jeffrey Modell Foundation s Global Genetic Sequencing Initiative Jeffrey s Insights

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesUnited kingdomAdam daleyFred modellChiesi farmaceuticiGiacomo chiesiB corpGroup chiesiGroup researchJeffrey modell centers networkInvitae primary immunodeficiency panelBerry company public relationsChiesi groupJeffrey modell foundationJeffrey modell centersGlobal rare diseases

Chiesi Global Rare Diseases Announces Updated U S Prescribing Information for FERRIPROX® (deferiprone)

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesUnited kingdomChiesi farmaceuticiB corpBerry company public relationsGroup chiesiChiesi groupGroup researchUs food drug administration approved indicationGlobal rare diseasesPrescribing informationDrug administration approved indicationImportant safetyDiamond blackfanBenefit corporationGlobal rare

vimarsana © 2020. All Rights Reserved.